Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.

Details for Australian Patent Application No. 2005209257 (hide)

Owner Amgen Inc.

Inventors Norman, Mark H.; Ognyanov, Vassil I.; Pettus, Liping H.

Agent Shelston IP

Pub. Number AU-A-2005209257

PCT Pub. Number WO2005/072681

Priority 60/538,704 23.01.04 US

Filing date 21 January 2005

Wipo publication date 11 August 2005

International Classifications

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 319/18 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072681 Priority application(s): WO2005/072681

14 September 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Vanilloid receptor ligands and their use in treatments

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209263-Heart valve assembly and methods for using them

2005209256-Use of adefovir or tenofovir for inhibiting MMTV-like viruses involved in breast cancer and primary biliary cirrhosis